OUTLOOK THERAPEUTICS INC is trading 12.9% up at $1.00 after Ascendiant Capital reiterated its Buy rating and significantly raised its price target.
- Ascendiant Capital increased its price target from $6.00 to $10.00, signaling substantial upside potential and a more aggressive outlook for the company.
- The stock continues to show bullish momentum following a 26.29% gain on June 10, 2026, as investors react to the positive analyst coverage and a supportive market environment.